Date Received: Nov 26, 2025
Date Accepted: Jul 28, 2026
Date Published: Sep 30, 2026
Views
Download
How to Cite:
African Swine Fever Vaccine Research and Deployment: A Review of Challenges and Future Directions in Vietnam’s Supervised Rollout
Keywords
African swine fever virus, live attenuated vaccines, vaccine safety, correlates of protection, DIVA strategy, regulatory policy
Abstract
African swine fever (ASF) continues to cause billions of dollars in global losses each year, disrupting pork supply chains and food security across Asia. This review analyzes the persistent gap between laboratory success and field performance of African swine fever vaccines, emphasizing live attenuated vaccines (LAVs) and hybrid next-generation platforms. It synthesizes recent findings on gene-deleted LAVs, encapsulin-based subunits, and mRNA or nanoparticle boosters that collectively aim to balance efficacy, safety, and DIVA compatibility. Key challenges include inconsistent protective efficacy, undefined immune correlates, and biosafety risks such as virulence reversion or recombination. Manufacturing constraints—dependence on porcine cell substrates, quality assurance, and scalability—compound system-level obstacles related to fragmented regulation and limited pharmacovigilance. Vietnam’s supervised rollout of NAVET-ASFVAC and AVAC ASF LIVE, with millions of doses deployed under strict monitoring, exemplifies a risk-managed model for national implementation. Looking ahead, coordinated regional governance, standardized challenge models, and harmonized regulatory frameworks are essential to translate next-generation hybrid vaccines into safe, scalable, and equitable ASF control strategies.
References
Acosta A., Lloyd T., McCorriston S. & Lan H. (2023). The ripple effect of animal disease outbreaks on food systems: The case of African Swine Fever on the Chinese pork market. Preventive Veterinary Medicine. 215: 105912.
Auer A., Cattoli G., Padungtod P., Lamien C. E., Oh Y., Jayme S. & Rozstalnyy A. (2024). Challenges in the application of African Swine Fever vaccines in Asia. Animals. 14(17): 2473.
Borca M. V., Ramirez-Medina E., Silva E., Vuono E., Rai A., Pruitt S., Holinka L. G., Velazquez-Salinas L., Zhu J & Gladue, D. P. (2020). Development of a Highly Effective African Swine Fever Virus Vaccine by Deletion of the I177L Gene Results in Sterile Immunity against the Current Epidemic Eurasia Strain. Journal of Virology. 94(7): e02017-19.
Borca M. V., Mutisya C., Ojuok R., Odaba J., Dihbol M., Lacasta A. & Gladue D. P. (2025). Evaluation of cross-protection of African Swine Fever vaccine ASFV-G-ΔI177L between ASFV biotypes. Vaccines. 13(8): 858.
Bui N. H., Vy T. T., Ngo N. B. A., Dam Q. K., Nguyen T. V. H., Tran T. C. G., Ambagala A. & Le V. P. (2025). ASF outbreaks in Vietnam (2019-2024): Insights and lessons learned. Veterinary Research Communications. 49: 307.
Chen W., Zhao D., He X., Liu R., Wang Z., Zhang X. & Bu Z. (2020). A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs. Science China Life Sciences. 63(5): 623-634.
Choi S. A., Kim Y., Lee S. J., Moon S. C., Ahn K. S., Zheng X., Kim D. S., Lee S. Y., Shin S. P., Tark D., Kim W., Shin Y., Jheong W. & Sur J. H. (2025). African Swine Fever vaccine candidate ASFV-G-ΔI177L/ΔLVR protects against homologous virulent challenge and exhibits long-term maintenance of antibodies. Animals. 15(4): 473.
Chu X., Ge S., Zuo Y., Cui J., Sha Z., Han N., Wu B., Ni B., Zhang H., Lv Y., Wang Z. & Xiao Y. (2024). Thoughts on the research of African Swine Fever live-attenuated vaccines. Vaccine. 42(25): 126052.
Chuong V. D., Schambow R. A., Diep N. T., Minh P. Q., Long N. V., To Nga B. T. & Perez A. M. (2025). Epidemiology and control of African swine fever in Vietnam: A scoping review. Pathogens. 14(4): 329.
Diep N. V., Duc N. V., Ngoc N. T., Dang V. X., Tiep T. N., Nguyen V. D., Than T. T., Maydaniuk D., Goonewardene K., Ambagala A. & Le V. P. (2024). Genotype II live-attenuated ASFV vaccine strains unable to completely protect pigs against the emerging recombinant ASFV genotype I/II strain in Vietnam. Vaccines. 12(10): 1114.
Diep N. V., Nguyen T. N., Nguyen V. D., Vu X. D., Tran N. T., Chu T. Q. & Bui T. T. (2025). Safety and efficacy profiles of the live attenuated vaccine AVAC ASF LIVE for preventing African swine fever in pigs. Transboundary and Emerging Diseases. 2025: 8623876. DOI: 10.1155/tbed/8623876.
Gladue D. P. & Borca M. V. (2022). Recombinant ASF live attenuated virus strains as experimental vaccine candidates. Viruses. 14(5): 878.
González-García G., Gallardo C., Montón M., Barroso-Arévalo S., Casado N., Barasona J. Á., Sánchez-Vizcaíno J. M., Venteo Á., Sastre P. & Rueda P. (2025). A novel prototype African swine fever virus DIVA (differentiation between infected and vaccinated animals) serological assay based on the detection of antibodies against the pEP153R, eGFP, and p72 proteins. Vaccines. 13(3): 211.
Lee S. J., Kim Y., Choi S. A., Ahn K. S., Lee S. Y., Zheng X., Kim D. S., Kim W., Shin Y., Kim J., Choi S., Tark D., Moon S. C., Jheong W. & Sur J. H. (2025). Safety of live attenuated ASFV-G-ΔI177L/ΔLVR vaccination in sows with advanced pregnancies. Transboundary and Emerging Diseases. 2025: 8007143.
Lee C. M., Suresh R., Boley P. A., Shekoni O. C., Schrock J., Dolatyabi S., Singh M., Khatiwada S. K., Bugybayeva D., Hanson J., Gourapura R. J. & Kenney S. P. (2026). Vaccination with an African swine fever virus multiepitope protein chitosan nanoparticle-based subunit vaccine elicits robust immune responses in vivo. Vaccines. 14(2): 187.
Liu Y., Shen Z., Xie Z., Song Y., Li Y., Liang R., Gong L., Di D., Liu J., Chen Z., Yu W., Lv L., Zhong Q., Liao X., Tian C., Wang R., Song Q., Wang H. & Chen H. (2023). African swine fever virus I73R is a critical virulence-related gene: A potential target for attenuation. Proceedings of the National Academy of Sciences. 120(15): e2210808120.
Liu J., Ding L., Chen W., Zhao D., Liu W., Liu Y., Li F., Liu R., Huo H., Zhu Y., Zhang H., Liu H., Tian Z. & Bu Z. (2026). Live-attenuated African swine fever vaccine HLJ/18-7GD is safe in pregnant sows with no impact on reproductive performance or offspring health at a field farm. Emerging Microbes and Infections. 15(1): 2614713.
Madden D. W., Artiaga B. L., Trujillo J. D., Assato P., McDowell C. D., Fitz I., Kwon T., Cool K., Li Y., Gaudreault N. N., Morozov I. & Richt J. A. (2025). Temporal dynamics of cytokine, leukocyte, and whole blood transcriptome profiles of pigs infected with African swine fever virus. bioRxiv. 2025: 673161.
Ministry of Agriculture and Rural Development (MARD) (2023). Official dispatch No. 4870/BNN-TY: Guidelines on safe and effective use of ASF vaccines in Vietnam. Hanoi. Retrieved from https://cucthuy.gov.vn/documents/20125/0/230724_CV_4870_Sudung_Vacxin_DTLCP+%281%29.pdf/5c856ff1-2800-4c71-dc2c-9a5f256c02dc?t=1690251806632 on September 25, 2025 (in Vietnamese).
Monteagudo P. L., Lacasta A., López E., Bosch L., Collado J., Pina-Pedrero S., Correa-Fiz F., Accensi F., Navas M. J., Vidal E., Bustos M. J., Rodríguez J. M. & Revilla Y. (2017). BA71ΔCD2: A new recombinant live attenuated African swine fever virus with cross-protective capabilities. Journal of Virology. 91(12): e01058–17.
Ngo T. T., Oh T. & Do D. T. (2026). The prospects and challenges of live attenuated vaccines against African swine fever virus in Vietnam. Vaccines. 14(3): 284.
Nguyen T. C., Bui N. T., Nguyen L. T., Ngo T. N., Van Nguyen C., Nguyen L. M., Nouhin J., Karlsson E., Padungtod P., Pamornchainavakul N., Kesdangsakonwut S., Thanawongnuwech R. & Do D. T. (2025). An African swine fever vaccine-like variant with multiple gene deletions caused reproductive failure in a Vietnamese breeding herd. Scientific Reports. 15(1): 14919. DOI: 10.1038/s41598-025-95641-3.
Ntakiyisumba E., Tanveer M. & Won G. (2025). A comprehensive analysis of the current strategy for developing live attenuated vaccines against African swine fever: A systematic review and meta-analysis. Vaccine. 57: 127243.
O'Dwyer J., Van H. V., Phuong N. T., Mileto P., Mercado O., da Conceição F., Jong J. B. D. C., Puana I., Neave M. J. & Williams D. T. (2025). Emergence of microvariants of African Swine Fever virus Genotype II in the Asia-Pacific. Transboundary and Emerging Diseases. 2025: 9990044. DOI: 10.1155/tbed/9990044.
Pedrera M., Soler A., Simón A., Casado N., Pérez C., Arias M. & Gallardo C. (2024). Characterization of the protective cellular immune response in pigs immunized intradermally with the live attenuated African Swine Fever virus (ASFV) Lv17/WB/Rie1. Vaccines. 12(4): 443.
Sunwoo Y., García-Belmonte R., Walczak M., Vigara-Astillero G., Kim M., Szymankiewicz K., Kochanowski M., Liu L., Tark D., Podgórska K., Revilla Y. & Pérez-Núñez D. (2024). Deletion of MGF505-2R gene activates the cGAS-STING pathway leading to attenuation and protection against virulent African Swine Fever virus. Vaccines. 12(4): 407.
Tran X. H., Le T. T. P., Nguyen Q. H., Do T. T., Nguyen V. D., Gay C. G., Borca M. V. & Gladue D. P. (2022). African Swine Fever virus vaccine candidate ASFV G ΔI177L efficiently protects European and native pig breeds against circulating Vietnamese field strain. Transboundary and Emerging Diseases. 69(7): e497-e504.
Vu H. L. & McVey D. S. (2024). Recent progress on gene-deleted live-attenuated African Swine Fever virus vaccines. NPJ Vaccines. 9(1): 1-10.
World Organisation for Animal Health (WOAH). (2023). Assessment of ASF vaccine deployment in Vietnam: Field data on AVAC ASF LIVE and NAVET-ASFVAC. Retrieved from https://rr-asia.woah.org/app/uploads/2024/12/6.2-ASF-vaccine-deployment-Vietnam.pdf on September 25, 2025.
Zhai H., Gao Y., Zhu Y., Hou Q., Wan N., Wang T., Li S., Zhao D., Qiu J. & Li Y. (2025). Anti-pA137R antibodies exacerbate the pathogenicity of African swine fever virus in pigs. Journal of Virology. 99(6): e00172-25.
Zhang H., Zhao S., Zhang H., Qin Z., Shan H. & Cai X. (2023). Vaccines for African Swine Fever: An update. Frontiers in Microbiology. 14: 1139494.
Zhang Y., Mei X., Zhang C., Wang H., Xie X., Zhang Z. & Feng Z. (2024). ASFV subunit vaccines: Strategies and prospects for future development. Microbial Pathogenesis. 197: 107063.
Zhang Y., Ru Y., Zhao L., Hao R., Yang Y., Shen C., Shi Z. & Zheng H. (2025). Encapsulin nanoparticle-conjugated p54 protein boosts immune responses against African Swine Fever virus. International Journal of Biological Macromolecules. 311: 131560.